1-8 of 8
Keiryn L Bennett
Close
Sort by
Journal Articles

Germline RBBP6 mutations in familial myeloproliferative neoplasms

Clinical Trials & Observations
Ashot S. Harutyunyan, Roberto Giambruno, Christian Krendl, Alexey Stukalov, Thorsten Klampfl, Tiina Berg, Doris Chen, Jelena D. Milosevic Feenstra, Roland Jäger, Bettina Gisslinger, Heinz Gisslinger, Elisa Rumi, Francesco Passamonti, Daniela Pietra, André C. Müller, Katja Parapatics, Florian P. Breitwieser, Richard Herrmann, Jacques Colinge, Keiryn L. Bennett, Giulio Superti-Furga, Mario Cazzola, Emma Hammond, Robert Kralovics
Journal: Blood
Blood (2016) 127 (3): 362–365.
https://doi.org/10.1182/blood-2015-09-668673
Published: 2016
Includes: Supplemental data
Journal Articles

Deficiency Of JAGN1 Causes Severe Congenital Neutropenia Associated With Defective Secretory Pathway and Aberrant Myeloid Cell Homeostasis

Kaan Boztug, Päivi M Järvinen, Elisabeth Salzer, Tomas Racek, PhD, Sebastian Mönch, Wojciech Garncarz, E. Michael Gertz, Alejandro A. Schäffer, Aristotelis Antonopoulos, Stuart Haslam, Lena Ziesenitz, Jacek Puchalka, Jana Diestelhorst, Giridharan Appaswamy, Brigitte Lescoeur, Roberto Giambruno, Johannes Bigenzahn, Ulrich Elling, Dietmar Pfeifer, Karl Welte, Prof. Dr. med., Gudrun Brandes, Roya Sherkat, Jutte Van der Werff Ten Bosch, Nima Rezaei, Amos Etzioni, Christine Bellanne-Chantelot, Giulio Superti-Furga, PhD, Keiryn L Bennett, PhD, Julia von Blume, Anne Dell, Jean Donadieu, Christoph Klein, MD PhD
Journal: Blood
Blood (2013) 122 (21): 439.
https://doi.org/10.1182/blood.V122.21.439.439
Published: 2013
Journal Articles

Germline RBBP6 Mutations In Myeloproliferative Neoplasms

Ashot S Harutyunyan, MD, Roberto Giambruno, Christian Krendl, Alexey Stukalov, PhD, Thorsten Klampfl, PhD, Tiina Berg, Jelena D. Milosevic, Doris Chen, PhD, Bettina Gisslinger, Heinz Gisslinger, MD, Elisa Rumi, MD, Francesco Passamonti, MD, Daniela Pietra, PhD, Andre Mueller, Katja Parapatics, Florian P Breitwieser, Richard Herrmann, MBBS, FRACP, FRCPA, Jacques Colinge, PhD, Keiryn L Bennett, PhD, Giulio Superti-Furga, PhD, Mario Cazzola, MD, Emma Hammond, PhD, Robert Kralovics, PhD
Journal: Blood
Blood (2013) 122 (21): 267.
https://doi.org/10.1182/blood.V122.21.267.267
Published: 2013
Journal Articles

KIT-D816V–independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib

Karoline V. Gleixner, Matthias Mayerhofer, Sabine Cerny-Reiterer, Gregor Hörmann, Uwe Rix, Keiryn L. Bennett, Emir Hadzijusufovic, Renata A. Meyer, Winfried F. Pickl, Jason Gotlib, Hans-Peter Horny, Andreas Reiter, Gerlinde Mitterbauer-Hohendanner, Giulio Superti-Furga, Peter Valent
Journal: Blood
Blood (2011) 118 (7): 1885–1898.
https://doi.org/10.1182/blood-2010-06-289959
Published: 2011
Includes: Supplemental data
Journal Articles

Functional Genomic and Proteomic Characterization of Normal and Oncogenic CEBPA Variants In Myeloid Cells

Florian Grebien, Roberto Giambruno, Keiryn L Bennett, Jacques Colinge, Giulio Superti-Furga
Journal: Blood
Blood (2010) 116 (21): 3873.
https://doi.org/10.1182/blood.V116.21.3873.3873
Published: 2010
Journal Articles

The effects of dasatinib on IgE receptor–dependent activation and histamine release in human basophils

Michael Kneidinger, Uwe Schmidt, Uwe Rix, Karoline V. Gleixner, Anja Vales, Christian Baumgartner, Christian Lupinek, Margit Weghofer, Keiryn L. Bennett, Harald Herrmann, Alexandra Schebesta, Wayne R. Thomas, Susanne Vrtala, Rudolf Valenta, Francis Y. Lee, Wilfried Ellmeier, Giulio Superti-Furga, Peter Valent
Journal: Blood
Blood (2008) 111 (6): 3097–3107.
https://doi.org/10.1182/blood-2007-08-104372
Published: 2008
Journal Articles

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

Uwe Rix, Oliver Hantschel, Gerhard Dürnberger, Lily L. Remsing Rix, Melanie Planyavsky, Nora V. Fernbach, Ines Kaupe, Keiryn L. Bennett, Peter Valent, Jacques Colinge, Thomas Köcher, Giulio Superti-Furga
Journal: Blood
Blood (2007) 110 (12): 4055–4063.
https://doi.org/10.1182/blood-2007-07-102061
Published: 2007
Includes: Supplemental data
Journal Articles

Systematic Profiling and Novel Targets of the Bcr-Abl Kinase Inhibitors Imatinib, Nilotinib and Dasatinib.

Oliver Hantschel, PhD, Uwe Rix, PhD, Tilmann Buerckstuemmer, PhD, Uwe Schmidt, PhD, Michael Kneidinger, MD, Keiryn L. Bennett, PhD, Ines Kaupe, BSc, Wilfried Ellmeier, PhD, Peter Valent, MD, Giulio Superti-Furga, PhD
Journal: Blood
Blood (2007) 110 (11): 4542.
https://doi.org/10.1182/blood.V110.11.4542.4542
Published: 2007